Synaptic scaling represents a homeostatic adjustment in synaptic strength that was first identified as a cell-wide mechanism to achieve firing rate homeostasis after perturbations to spiking activity levels. In this review, we consider a form of synaptic scaling that is triggered by changes in action potential-independent neurotransmitter release. This plasticity appears to be both triggered and expressed locally at the dendritic site of the synapse that experiences a perturbation. A discussion of different forms of scaling triggered by different perturbations is presented. We consider work from multiple groups supporting this form of scaling, which we call neurotransmission-based scaling. This class of homeostatic synaptic plasticity is compared in studies using hippocampal and cortical cultures, as well as in vivo work in the embryonic chick spinal cord. Despite differences in the tissues examined, there are clear similarities in neurotransmission-based scaling, which appear to be molecularly distinct from the originally described spike-based scaling. (Turrigiano, 2012; Turrigiano, Leslie, Desai, Rutherford, & Nelson, 1998) . This increase occurred across the entire distribution of mEPSC amplitudes in a multiplicative or "scaled" manner (e.g., all amplitudes became twice as large); in this way relative differences in synaptic strength achieved through Hebbian means were maintained. This initial study showed that 2-day block of either APs with TTX or AMPA receptor activation (AMPAergic transmission) with CNQX triggered upward scaling, which was mediated by an increase in the postsynaptic sensitivity to glutamate. These initial results have proven extremely robust, as they have been identified in hippocampal primary cultures and slices, spinal cultures, as well as many other tissues in vitro and in vivo (Deeg & Aizenman, 2011; Goel et al., 2006; Gonzalez-Islas Significance Homeostatic synaptic scaling is thought to prevent inappropriate levels of spiking activity through compensatory adjustments in the strength of synaptic inputs. Therefore, it is thought that scaling is triggered by perturbations in spiking. In this review, we discuss a form of synaptic scaling that is triggered in an action potential-independent manner, through alterations in the frequency of miniature postsynaptic currents once thought to be functionally unimportant. The results raise the possibility that profound changes in synaptic strength, and therefore network excitability, could be influenced by any chronic disruption of spontaneous neurotransmitter release.
that when spike activity was blocked for days in cultured cortical networks, neurons responded in what appeared to be a compensatory direction by increasing the strength of all their excitatory synaptic inputs, as measured by miniature excitatory postsynaptic current (mEPSC) amplitude (Turrigiano, 2012; Turrigiano, Leslie, Desai, Rutherford, & Nelson, 1998) . This increase occurred across the entire distribution of mEPSC amplitudes in a multiplicative or "scaled" manner (e.g., all amplitudes became twice as large); in this way relative differences in synaptic strength achieved through Hebbian means were maintained. This initial study showed that 2-day block of either APs with TTX or AMPA receptor activation (AMPAergic transmission) with CNQX triggered upward scaling, which was mediated by an increase in the postsynaptic sensitivity to glutamate. These initial results have proven extremely robust, as they have been identified in hippocampal primary cultures and slices, spinal cultures, as well as many other tissues in vitro and in vivo (Deeg & Aizenman, 2011; Goel et al., 2006; Gonzalez-Islas Significance Homeostatic synaptic scaling is thought to prevent inappropriate levels of spiking activity through compensatory adjustments in the strength of synaptic inputs. Therefore, it is thought that scaling is triggered by perturbations in spiking. In this review, we discuss a form of synaptic scaling that is triggered in an action potential-independent manner, through alterations in the frequency of miniature postsynaptic currents once thought to be functionally unimportant. The results raise the possibility that profound changes in synaptic strength, and therefore network excitability, could be influenced by any chronic disruption of spontaneous neurotransmitter release. & Wenner, 2006; O'Brien et al., 1998; Thiagarajan, Piedras-Renteria, & Tsien, 2002) . Scaling has been proposed to act to contribute to the homeostatic maintenance of spiking levels, which is thought to be triggered by reduced spiking to restore the spike rate to a set point. However, the picture has become more complicated as recent observations demonstrate that scaling can be triggered by altering AP-independent spontaneous release. We will now discuss these reports as they relate to divergent experimental systems. to AP-independent spontaneous release of glutamatergic vesicles triggers scaling (Aoto, Nam, Poon, Ting, & Chen, 2008; Reese & Kavalali, 2015; Sutton et al., 2006) . The studies consistently suggested that spontaneous release of glutamate opened NMDARs leading to local calcium elevations, which normally inhibited translation of GluA1 through eEF2K (eukaryotic elongation factor 2 kinase) and prevented synaptic upscaling. When this signaling cascade was interrupted, GluA2-lacking (GluA1-containing) AMPARs were inserted into the synaptic membrane and mediated upscaling.
Initial studies by Erin Schuman and Michael Sutton showed that scaling could be triggered in just 4 hr by blocking spiking activity and NMDARs with TTX and an NMDAR antagonist (APV) or just APV, while 4-hr blockade of spiking alone (TTX) did not trigger scaling (Jakawich et al., 2010; Sutton et al., 2006; Sutton, Taylor, Ito, Pham, & Schuman, 2007) . Therefore, scaling was only triggered when NMDAergic mPSCs were blocked. By puffing different drugs locally on a part of the dendrite, the authors went on to show that this fast form of synaptic compensation was actually a process that occurred locally in the dendrite. When NMDA neurotransmission was blocked, calcium entry was reduced, subsequently reducing Ca 21 -calmodulin activation of eEF2K, leading to the activation of eEF2 and thereby enhancing dendritic translation ( Figure 1) (Sutton et al., 2007) . Therefore, blocking miniature-induced calcium entry enhanced local translation, leading to an increase in synaptic strength. The studies demonstrated that this GluA1-mediated scaling could also be triggered in primary hippocampal slices and that such scaling was also observed over longer incubations of TTX/APV (24 1 hr). The results were particularly important because they suggested that synaptic compensations could be triggered by blocking NMDA miniature events and that this local synaptic homeostasis could take the form of global cell-wide scaling if all NMDA miniature events in a cell or cultured network were blocked. Lu Chen's group has also demonstrated upward scaling in hippocampal primary cultures and organotypic hippocampal slices following 24-to 36-hr blockade of NMDA miniature transmission (TTX 1 APV; Aoto et al., 2008) . Several advances were made in these studies as a previously unrecognized pathway was found to be responsible for the upward scaling (Figure 1 ). The work suggested that reductions in calcium entry due to NMDAergic mPSCs disinhibited retinoic acid (RA) synthesis through calcineurin (Aoto et al., 2008; Arendt et al., 2015) .
Increases in RA lead to scaling by binding to its receptor, RARa, which normally acts to prevent translation of GluA1 mRNA . Another critical insight from these studies was the demonstration that FMRP (fragile X mental retardation protein) was necessary for this form of AMPAergic upward scaling (Soden & Chen, 2010) .
| Reducing spontaneous glutamate vesicle release triggers scaling
The studies above assume that this form of upward scaling is mediated by the blockade of calcium entry through NMDARs that occur because of spontaneous glutamatergic vesicle release. These would be rather small calcium signals, and it was not completely clear how these signals could impact calcium signaling cascades in the cell. A third group (Ege Kavalali) has elegantly demonstrated how such a signaling cascade could occur mechanistically. This group was able to show that NMDA miniature transmission produced discernible calcium signals that were dependent on ryanodine-sensitive calcium-induced calcium release (Reese & Kavalali, 2015) , which amplified the calcium signal ( Figure 1) . Normally, such signaling suppressed scaling through activation of the eEF2K. Blockade of ryanodine receptors and the associated calcium transients triggered scaling, and this was prevented in eEF2K KO neurons (Reese & Kavalali, 2015) . In addition, the earlier work argues that glutamatergic spontaneous release is critical to the triggering of upward scaling, at least when activity is coincidentally blocked. This idea was consistent with the possibility that reducing spontaneous glutamatergic release alone (without changes in evoked release or spiking) could trigger scaling. It has now been demonstrated in two recent reports that AMPAergic upward scaling can be triggered by specifically reducing the frequency of glutamate spontaneous release, while leaving evoked release intact Ramirez et al., 2017) .
These studies used a genetic knockdown strategy where the expression of two different sets of synaptic vesicle proteins (VAMP7/vti1a or Doc2-like protein family) were reduced selectively, lowering mEPSC frequency for days and triggering an upward scaling. Further, upscaling triggered in this way was dependent on eEF2K.
| AMPAergic upscaling triggered by different methods
The discussion thus far has focused on upward scaling triggered by blockade of NMDA miniature transmission. However, upward since AMPAR antagonist application also triggered scaling at 3 and 24 1 hr of treatment; likewise, all of these treatments led to scaling that was mediated by GluA2-lacking AMPARs and that was dependent on RA synthesis (Jakawich et al., 2010; Thiagarajan et al., 2002 Thiagarajan et al., , 2005 Wang et al., 2011) .
While there are differences in these studies across labs, it is more impressive how well the experimental results agree. Taken together, the most parsimonious explanation for upward AMPAergic synaptic scaling in hippocampal tissue is that reductions in calcium entry due to reduced miniature NMDAR or AMPAR transmission trigger a cascade in the postsynaptic cell that is proposed in Figure 1 . In this model, upward AMPAergic scaling is triggered by reductions in miniature calcium entry, which would occur following chronic reductions in glutamate vesicle release or reductions in miniature activation of NMDARs or AMPARs. Reduced dendritic calcium would lead to activation of eEF2, which is important for elongation during protein translation (Ryazanov, Shestakova, & Natapov, 1988 ) and also would be necessary to disinhibit translation of GluA1 mRNA in the dendrite . In this way, preventing either protein elongation or disinhibition of GluA1 translation would inhibit scaling. We are proposing that any of these perturbations to miniature transmission trigger a similar form of transmission-based scaling. On the other hand, AMPAergic upscaling that is triggered by spike blockade alone (TTX) appears to be a different form of scaling (Turrigiano, 2012) . TTXbased scaling typically takes 24 to 48 hr to be expressed, is not dependent on FMRP or RA synthesis, is mediated by changes in transcription rather than translation, and involves increases in GluA2-containing AMPARs (Ibata, Sun, & Turrigiano, 2008; Soden & Chen, 2010; Sutton et al., 2006; Turrigiano, 2011; Wang et al., 2011) . The findings raise the probability that there will be many different molecular components and pathways that are necessary for the appropriate expression of scaling.
| C ORTI C AL P R IM A R Y C ULTUR ES
Thus far, all the work on miniature transmission-based scaling that we have discussed has been observed in hippocampal cultures. How   FIG URE 1 Models describing the possible molecular pathways that mediate neurotransmission-based scaling in hippocampal cultures. The normal signaling cascades that operate when miniature transmission is intact and AMPAergic upscaling is not triggered are shown on the left. When calcium entry due to miniature neurotransmission is prevented from entering the cell, AMPAergic upscaling is triggered; the molecular pathways are shown on the right widespread is this phenomenon? There is a multitude of evidence that upward AMPAergic scaling can be triggered by chronic blockade of AMPAergic transmission. This has been shown in the original study when 2-day CNQX treatment triggered scaling of cortical cultured neurons (Turrigiano et al., 1998) , but it has also been seen in several other studies (O'Brien et al., 1998; Stellwagen & Malenka, 2006) . Because scaling that is triggered by glutamatergic receptor blockade appears to be similar to scaling triggered by blocking miniature transmission in the hippocampus, it is very possible that this similarity carries over to other parts of the nervous system. In fact, we have recently shown in cortical cultures that the scaling up produced by 24-hr spike blockade can be attenuated by increasing AP-independent spontaneous neurotransmission (Fong, Newman, Potter, & Wenner, 2015) . We did this by coapplying TTX and cyclothiazide, which produced an acute increase of mEPSC amplitude and frequency in the presence of spike blockade.
This result suggested that miniature transmission influences AMPAergic scaling in cortical cultures as well as hippocampal cultures. Lidocaine treatment blocked embryonic movements, which did not recover over the 2-day infusion. However, blockade of either GABARs or glutamate receptors only initially blocked embryonic movements, which then homeostatically recovered to control levels after 12 hr of drug treatment. Consistent with the idea that scaling in the embryonic spinal cord was a transmission-based plasticity, we found that blocking
GABAergic, but not glutamatergic, transmission for 2 days in vivo was also capable of triggering upward scaling of AMPA and GABA mPSCs (Wilhelm & Wenner, 2008) . This form of plasticity appeared to be similar to the lidocaine-triggered scaling up as the mechanisms of scaling were the same: insertion of GluA2-lacking AMPARs (Garcia-Bereguiain et al., 2013) and chloride accumulation (Lindsly, Gonzalez-Islas, & Wenner, 2014 ).
We had assumed that GABAergic transmission associated with the bouts of spiking activity were key to the scaling process; however, this turned out to be incorrect. We made the striking discovery that we could trigger upward scaling to the same extent (amplitude) as complete GABA A receptor blockade by mildly reducing the frequency of AP-independent GABA vesicle release (Gonzalez-Islas, GarciaBereguiain, O'Flaherty, & Wenner, 2015; Garcia-Bereguiain, GonzalezIslas, Lindsly, & Wenner, 2016) . This was done in vivo by presynaptically manipulating spontaneous GABA release with nicotinic agents.
Further arguing the importance of miniature GABAergic neurotransmission, we found that increasing spontaneous GABA vesicle release could trigger a downscaling of AMPA and GABA mPSC amplitude. In fact, when we blocked spiking with lidocaine while increasing GABA spontaneous release, we converted the upscaling observed with lidocaine alone to downscaling. These results demonstrate the importance of GABAergic spontaneous release in triggering upscaling and downscaling of AMPA and GABA mPSCs in the living system.
The studies in the embryonic chick spinal cord represent the first demonstration that reducing miniature transmission can trigger an upscaling of GABAergic mPSCs. However, previous work has shown that blocking the miniature NMDAergic signaling cascade mediated by RA can trigger GABAergic downscaling (Sarti, Zhang, Schroeder, & Chen, 2013) . While these two studies may appear to be distinct, reducing miniature transmission functionally leads to an increase in excitability in both systems as one increases quantal GABAergic depolarizations (embryo) and the other decreases quantal GABAergic inhibition (hippocampal culture). It should be noted that a third study has shown that reducing spontaneous release of both GABA and glutamate did not lead to GABAergic scaling in hippocampal cultures .
In embryonic spinal neurons, GABA is depolarizing, and so it will be important to determine whether GABAergic mPSCs produce depolarizations that are capable of opening voltage-gated calcium channels that then trigger similar cascades to those that mediate transmissionbased scaling in cultured networks. It is possible that GABA mPSCs can signal these pathways early in development when they are depolarizing, but that as the system matures and GABA becomes hyperpolarizing, glutamatergic mPSCs may take over the role of GABAergic mPSCs in triggering scaling. The results also provide a cautionary tale in terms of the potential impact of any genetic disorders or pharmacological exposures to the developing nervous system that may alter GABAergic spontaneous release (e.g., nicotine).
| C ONC LUSI ON S
The recent findings that link spontaneous release to transmission- 
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